136 related articles for article (PubMed ID: 32099471)
1. The Correlation Between Computed Tomography Volumetry and Prognosis of Advanced Gastric Cancer Treated with Neoadjuvant Chemotherapy.
Chen C; Dong H; Shou C; Shi X; Zhang Q; Liu X; Zhu K; Zhong B; Yu J
Cancer Manag Res; 2020; 12():759-768. PubMed ID: 32099471
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer.
Lee SM; Kim SH; Lee JM; Im SA; Bang YJ; Kim WH; Kim MA; Yang HK; Lee HJ; Kang WJ; Han JK; Choi BI
Abdom Imaging; 2009 Jul; 34(4):430-40. PubMed ID: 18546037
[TBL] [Abstract][Full Text] [Related]
3. Can low-dose CT perfusion imaging accurately assess response of advanced gastric cancer with neoadjuvant chemotherapy?
Sun ZQ; Yan G; Ge YX; Li J; Jin LF; Xie ZH; Zhao P
J Xray Sci Technol; 2017; 25(6):981-991. PubMed ID: 28697579
[TBL] [Abstract][Full Text] [Related]
4.
Mi L; Zhao Y; Zhao X; Yin F; Yin X; Li N; Shi J; Han X; Duan X; Zhao M; Han G; Wang J
Cancer Biother Radiopharm; 2021 Oct; 36(8):662-671. PubMed ID: 32783634
[No Abstract] [Full Text] [Related]
5. Utility of MRI and PET/CT after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity.
Kim T; Kang DK; An YS; Yim H; Jung YS; Kim KS; Kang SY; Kim TH
Acta Radiol; 2014 May; 55(4):399-408. PubMed ID: 23963151
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
Ács B; Zámbó V; Vízkeleti L; Szász AM; Madaras L; Szentmártoni G; Tőkés T; Molnár BÁ; Molnár IA; Vári-Kakas S; Kulka J; Tőkés AM
Diagn Pathol; 2017 Feb; 12(1):20. PubMed ID: 28222768
[TBL] [Abstract][Full Text] [Related]
7. [Value of double contrast-enhanced ultrasound QontraXt three-dimensional pseudocolor quantitative analysis to therapeutic effect evaluation of preoperative neoadjuvant chemotherapy in advanced gastric cancer patients].
Yan CX; Huang PT; Shentu WH; Lin ZM; Li J; Zhang Y; Xu JH; Jin XL
Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):857-863. PubMed ID: 30481939
[No Abstract] [Full Text] [Related]
8. Contrast-enhanced ultrasonography assessment of gastric cancer response to neoadjuvant chemotherapy.
Ang J; Hu L; Huang PT; Wu JX; Huang LN; Cao CH; Zheng YX; Chen L
World J Gastroenterol; 2012 Dec; 18(47):7026-32. PubMed ID: 23323004
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
[TBL] [Abstract][Full Text] [Related]
10. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
11. Predictive Ability of
Kiyoto S; Sugawara Y; Hosokawa K; Nishimura R; Yamashita N; Ohsumi S; Mochizuki T
Asia Ocean J Nucl Med Biol; 2016; 4(1):3-11. PubMed ID: 27904868
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
13. Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer).
Mazzei MA; Di Giacomo L; Bagnacci G; Nardone V; Gentili F; Lucii G; Tini P; Marrelli D; Morgagni P; Mura G; Baiocchi GL; Pittiani F; Volterrani L; Roviello F
Quant Imaging Med Surg; 2021 Jun; 11(6):2376-2387. PubMed ID: 34079708
[TBL] [Abstract][Full Text] [Related]
14. Decrease in Blood Neutrophil-to-Lymphocyte Ratio Indicates Better Survival After Neoadjuvant Chemotherapy in Patients With Advanced Gastric Cancer.
Liu Z; Liang Y; Tang X; Qu H
Front Surg; 2021; 8():745748. PubMed ID: 34869556
[No Abstract] [Full Text] [Related]
15. Complete Metabolic Response on Interim
Chen S; Ibrahim NK; Yan Y; Wong ST; Wang H; Wong FC
Oncologist; 2017 May; 22(5):526-534. PubMed ID: 28377466
[TBL] [Abstract][Full Text] [Related]
16. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of interim
Lee SY; Seo HJ; Kim S; Eo JS; Oh SC
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e302-e309. PubMed ID: 29226597
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis.
Ge L; Wang HJ; Yin D; Lei C; Zhu JF; Cai XH; Zhang GQ
World J Gastroenterol; 2012 Dec; 18(48):7384-93. PubMed ID: 23326149
[TBL] [Abstract][Full Text] [Related]
19. Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer.
Chen YH; Xiao J; Chen XJ; Wang HS; Liu D; Xiang J; Peng JS
World J Gastroenterol; 2020 May; 26(19):2427-2439. PubMed ID: 32476803
[TBL] [Abstract][Full Text] [Related]
20. MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy.
Nougaret S; Rouanet P; Molinari N; Pierredon MA; Bibeau F; Azria D; Lemanski C; Assenat E; Duffour J; Ychou M; Reinhold C; Gallix B
Radiology; 2012 May; 263(2):409-18. PubMed ID: 22438364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
